Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants
Source check: Source checked. Not independent scientific confirmation.
Finding: Analysis of donor-lung transcriptomes before and after ex-vivo lung perfusion identified UGCG, SAMD8 and MED26 as upregulated lipid-metabolism genes associated with natural-killer-cell states. Biomarker AUCs were 0.986 in GSE127057 and 0.922 in the independent GSE127055 cohort; a mouse EVLP model reproduced increased expression of all three genes. Expression and immune-cell associations do not establish causal regulation or clinical utility.
Technology: WGCNA with LASSO, random forest and XGBoost feature analysis
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning feature selection prioritized lipid-metabolism genes in donor-lung expression data; separate murine EVLP experiments checked expression changes.
- Test and result
- WGCNA and LASSO, random forest and XGBoost prioritized genes in GSE127057; GSE127055 provided independent cohort validation. Murine EVLP experiments assessed gene expression and reproduced upregulation of UGCG, SAMD8 and MED26.
- Limitation / still unknown
- Gene-expression and immune-cell correlations do not establish causal regulation; clinical monitoring or treatment benefit was not tested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12433055/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.